Osaka, Japan - June 17, 2021 - Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) today announced the launch of eight generic drugs with 23 strengths. They will be launched sequentially beginning June 18, 2021. Sawai’s product line now includes 327 compounds with 808 strengths.
The list of new products
1. Eszopiclone Tablets
| Generic name |
Eszopiclone |
| Strengths |
1mg, 2mg, 3mg |
| Brand products |
Lunesta® Tablets 1mg, 2mg, 3mg |
2. Solifenacin Succinate Tablets, OD Tablets
| Generic name |
Solifenacin Succinate |
| Strengths |
Tablets, OD Tablets: 2.5mg, 5mg |
| Brand products |
Vesicare® Tablets 2.5mg, 5mg, Vesicare® OD Tablets 2.5mg, 5mg |
3. Zilmlo® Combination Tablets, OD Tablets
| Generic name |
Azilsartan, Amlodipine |
| Strengths |
LD, HD |
| Brand products |
ZACRAS® Combination Tablets LD&HD |
4. Epinastine Hydrochloride Ophthalmic Solution
| Generic name |
Epinastine Hydrochloride |
| Strengths |
0.05% |
| Brand products |
ALESION® Ophthalmic Solution 0.05% |
5. Duloxetine Capsules
| Generic name |
Duloxetine Hydrochloride |
| Strengths |
20mg, 30mg |
| Brand products |
Cymbalta® Capsules 20mg, 30mg |
6. Tadalafil Tablets AD
| Generic name |
Tadalafil |
| Strengths |
20mg |
| Brand products |
Adcirca® Tablets 20mg |
7. Pemetrexed for Intravenous Infusion, Intravenous Infusion
| Generic name |
Pemetrexed |
| Strengths |
For Intravenous Infusion 100mg, 500mg, 800mg,
Intravenous Infusion 100mg, 500mg, 800mg |
| Brand products |
Alimta® Injection 100mg, 500mg |
8. Deferasirox Granules
| Generic name |
Deferasirox |
| Strengths |
90mg, 360mg |
| Brand products |
JADENU® Granules Sachet 90mg, 360mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.
